Search
All Clinical Trials
A listing of 24452 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
24361 - 24372 of 24452
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Healthy Volunteer Trials
Recruiting
Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Healthy
Featured Trial
Chronic Cough Clinical Study
Recruiting
We are evaluating an investigational treatment to see if it may help people dealing with chronic cough.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required.
Conditions:
Cough
Chronic Cough
Asthma
Allergic Asthma
Sinusitis
Featured Trial
High blood pressure (Hypertension) Trials
Recruiting
High blood pressure (Hypertension) trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
High blood pressure (Hypertension)
Featured Trial
Cardiovascular Disease Trials
Recruiting
Cardiovascular Disease trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Cardiovascular Disease
Featured Trial
Migraine Trials
Recruiting
Migraine trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Migraine
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
Recruiting
Sarcoidosis is a multi-system granulomatous disorder that is triggered and influenced by gene-environment interactions. Although sarcoidosis predominantly affects the lungs in most cases, the clinical disease course is highly variable and any organ can be affected leading to end organ damage despite currently available therapeutics that unfortunately also have numerous and potentially devastating side effects. The environmental triggers of sarcoidosis are unknown but several occupational, enviro... Read More
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
05/04/2020
Locations: University of California, San Francisco (Parnassus), San Francisco, California
Conditions: Sarcoidosis, Sarcoidosis, Pulmonary
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
Recruiting
This is a prospective study, involving contacting potential plasma donors and the use of their plasma to help fight off infections of those suffering from COVID19 in accordance to collection guidelines for plasma and FDA IND requirement. This study will include up to 240 participants potentially receiving convalescent plasma and up to 1000 potential donors.
There are 3 basic arms to the study: mild, moderate and severe/critical severity. All 3 severity groups are eligible for enrollment, but mi... Read More
Gender:
All
Ages:
31 days and above
Trial Updated:
05/01/2020
Locations: WVU Medicine, Morgantown, West Virginia
Cerclage for Twins With Short Cervical Length ≤ 15mm
Recruiting
This is a multicenter randomized study designed to determine if ultrasound indicated cerclage reduces the incidence of spontaneous preterm birth <34 weeks in asymptomatic women with twin gestations and cervical length ≤15mm, diagnosed by transvaginal ultrasound between 16 to 23 6/7 weeks of gestation.
Gender:
Female
Ages:
Between 18 years and 60 years
Trial Updated:
04/23/2020
Locations: George Washington University, Washington, District of Columbia +7 locations
Conditions: Twin Pregnancy With Antenatal Problem, Preterm Birth, Short Cervix
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)
Recruiting
The purpose of this study is to test the hypothesis that post-exposure prophylaxis with hydroxychloroquine will reduce the symptomatic secondary attack rate among household contacts of known or suspected COVID-19 patients.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2020
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: COVID-19, Corona Virus Infection
Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
Recruiting
Neoadjuvant chemotherapy (NACT) can induce complete pathologic response (pCR) in approximately 35-55% of patient with triple-negative breast cancer (TNBC). These patients have excellent long term survivals. On the other hand patients with residual disease exhibit a high rate of local or metastatic. Although it has been successful in some regards, randomized trials have shown similar rates of mortality between patients receiving NACT and adjuvant chemotherapy (ACT). The goal of this study is to u... Read More
Gender:
Female
Ages:
Between 18 years and 86 years
Trial Updated:
04/22/2020
Locations: Texas Tech University Health Sciences Center- El Paso, El Paso, Texas
Conditions: Triple-negative Breast Cancer
Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata
Recruiting
The primary objective of this study is to evaluate the safety and efficacy of the use of a biocellular mixture of emulsified adipose-derived tissue stromal vascular fraction (AD-tSVF) and high density platelet-rich plasma concentrate (HD- PRP). Additionally, comparison with clinical outcomes of adipose-derived cellular Stromal Vascular Fraction (AD-cSVF) + AD-tSVF + HD PRP; AD-cSVF + emulsified AD-tSVF + HD- PRP; emulsified AD-tSVF + HD PRP + AD-cSVF; AD-cSVF via intravenous infusion in treatmen... Read More
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
04/15/2020
Locations: Kenneth Williams, DO, Irvine, California +2 locations
Conditions: Alopecia Areata, Scarring Alopecia
Gentamicin for Junctional Epidermolysis Bullosa
Recruiting
Herlitz junctional epidermolysis bullosa (H-JEB), an incurable, fatal, inherited skin disease, is caused by loss-of-function mutations in the LAMA3, LAMB3 or LAMC2 genes, resulting in loss of laminin 332 and poor epidermal-dermal adherence. Eighty percent of H-JEB patients have LAMB3 mutations and about 95% of these are nonsense mutations. The investigators recently demonstrated that gentamicin readily induced nonsense mutation readthrough and produced full-length laminin beta3 in several nonsen... Read More
Gender:
All
Ages:
All
Trial Updated:
04/03/2020
Locations: University of Southern California, Los Angeles, California
Conditions: Junctional Epidermolysis Bullosa
Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2
Recruiting
This study will be a multi-institutional randomized clinical trial of a short course of pre-operative antibiotic prophylaxis in addition to perioperative antibiotics prior to undergoing percutaneous nephrolithotomy. The select patient population will be those patients deemed to be at a moderately increased risk of postoperative infectious complications. These higher risk patients are those with indwelling urinary drainage tubes and those with a positive preoperative urine culture.
Gender:
All
Ages:
All
Trial Updated:
03/23/2020
Locations: University of California San Diego, San Diego, California
Conditions: Nephrolithiasis, Urinary Tract Infection (UTI), Sepsis
Antibiotic Prophylaxis With Routine Ureteral Stent Removal
Recruiting
This study will be a single-institutional randomized, single-blinded prospectively controlled clinical trial of a single dose of Ciprofloxicin 500mg antibiotic tablet as prophylaxis at the time of office flexible cystoscopy with ureteral stent removal. The control group will be no prophylaxis oral antibiotics.
Gender:
All
Ages:
All
Trial Updated:
03/23/2020
Locations: University of California, San Diego, San Diego, California
Conditions: Urolithiasis, UTI
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
Recruiting
The purpose of this pilot study will be to conduct a clinical trial using a time-of-flight PET scanner and MRI scanner to test an improved method for differentiating tumor recurrence from radiation necrosis in glioblastoma patients. We will attempt to do so by performing a static and dynamic FDG-PET scan, a static and dynamic FDOPA-PET scan, and a multiparametric MRI scan - then comparing the results with surgical pathology and static FDG-PET scans. We hypothesize that the new quantitative kinet... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/20/2020
Locations: University of Virginia, Charlottesville, Virginia
Conditions: Glioblastoma
The Healthy Elderly Longevity Cohort
Recruiting
With the completion of the human genome project, investigators can now explore new questions in human biology. Previously human genetics focused on highly penetrant, Mendelian traits; however, now rare and common variants can be discovered that affect "common" diseases that have multi-gene architecture with variable penetrance such as breast cancer, diabetes mellitus, and coronary artery disease. This change took place because investigators now have the tools to illuminate the whole genome at on... Read More
Gender:
All
Ages:
80 years and above
Trial Updated:
03/16/2020
Locations: Scripps Translational Science Institute, La Jolla, California
Conditions: Healthy
TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory
Recruiting
The purpose of this study is to assess the effects of non-invasive brain stimulation on memory in cognitively unimpaired older adults and in patients amnestic mild cognitive impairment (aMCI) due to Alzheimer's disease (AD). This study will use repetitive Transcranial Magnetic Stimulation (rTMS) to stimulate nodes of the Default Mode Network (DMN)- which is thought to support episodic memory and to be affected by Alzheimer's pathology.
We will use functional connectivity MRI (fcMRI) to assess c... Read More
Gender:
All
Ages:
Between 60 years and 85 years
Trial Updated:
03/11/2020
Locations: Massachuetts General Hospital, Charlestown, Massachusetts
Conditions: Alzheimer Disease, Mild Cognitive Impairment, Aging
24361 - 24372 of 24452